What is AtriCure's D&A?

AtriCure (ATRC) reported D&A of $2.89M in Q1 2026.

How has AtriCure's D&A changed year-over-year?

AtriCure's D&A decreased by 2.9% year-over-year, from $2.97M to $2.89M.

What is the long-term trend for AtriCure's D&A?

Over 4 years (2021 to 2025), AtriCure's D&A has grown at a 12.6% compound annual growth rate (CAGR), from $7.53M to $12.09M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

AtriCure ATRC D&A

D&A at other companies

Johnson & JohnsonJNJ

$2B+13.1%

Boston ScientificBSX

$351M+8.0%

MedtronicMDT

$716M-14.8%

Pulse Biosciences, Inc.PLSE

$88K-24.8%

ITG

Integer HoldingsITGR

$35.01M+17.4%

Avanos MedicalAVNS

$10.2M+6.3%

Other financials

Income statement

See full

Revenue$141.2M+14.3%

Gross profit$109.3M+18.0%

Operating income$526.0K+109%

Net income$108.0K+102%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$146.2M+46.3%

Total debt$76.2M-3.1%

Total equity$491.7M+8.2%

Total assets$644.0M+8.8%

Cash flow

See full

Operating cash flow-$4.0M+63.8%

CapEx$3.9M+76.6%

Free cash flow-$7.8M+40.6%

Valuation

See full

Market cap$1.43B-9.9%

Enterprise value$1.36B-13.1%

P/S2.6×-0.7×

Profitability

See full

Gross margin75.6%+0.8pp

Operating margin-5.1%-1.3pp

Net margin-5.6%-1.5pp

FCF margin9.7%—

Returns & leverage

See full

Return on equity-6.1%-1.3pp

Debt / equity0.2×0.0×

Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AtriCure's D&A?: AtriCure (ATRC) reported D&A of $2.89M in Q1 2026.
How has AtriCure's D&A changed year-over-year?: AtriCure's D&A decreased by 2.9% year-over-year, from $2.97M to $2.89M.
What is the long-term trend for AtriCure's D&A?: Over 4 years (2021 to 2025), AtriCure's D&A has grown at a 12.6% compound annual growth rate (CAGR), from $7.53M to $12.09M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.